Loading...
Development of Lipid–Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin
Enoxaparin, an anticoagulant that helps prevent the formation of blood clots, is administered parenterally. Here, we report the development and evaluation of lipid–polymer hybrid nanoparticles (LPHNs) for the oral delivery of enoxaparin. The polymer poloxamer 407 (P407) was incorporated into lipid n...
Saved in:
| Published in: | Pharmaceutics |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7407632/ https://ncbi.nlm.nih.gov/pubmed/32629827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12070607 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|